Serina Therapeutics, Inc. (SER) — DEF 14A Filings
All DEF 14A filings from Serina Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Serina Therapeutics Sets Virtual Annual Meeting, Seeks Director Re-election & Convertible Note Approval
— Sep 26, 2025 Risk: medium
Serina Therapeutics, Inc. (SER) is holding its Annual Meeting of Stockholders on November 7, 2025, as a virtual-only event. Key proposals include the re-electio -
Serina Therapeutics Files Definitive Proxy Statement
— Nov 6, 2024 Risk: low
Serina Therapeutics, Inc. filed its definitive proxy statement on November 6, 2024, for its annual meeting of stockholders on December 13, 2024. The company, fo
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX